Vaxicare Enterprises Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 2.20 Cr
- Revenue Growth 14.14%
- Profit Growth 13.95%
- Ebitda -23.53%
- Net Worth 58.82%
- Total Assets 33.71%
About Vaxicare Enterprises
Vaxicare Enterprises Private Limited (VEPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 April 2019 (Five years and nine months 16 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.20 Cr.
Bharti and Manoj Nailwal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51909DL2019PTC348758
- Company No.
348758
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2019
- Date of AGM
29 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Vaxicare Enterprises Private Limited offer?
Vaxicare Enterprises Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Immunization & Vaccination Drugs, Vaccines, Sexual Wellness Products, Fertility Enhancer, Contraceptives, Anticoagulant and Antiplatelet Drugs, Enoxaparin Injection, Antibacterial Drugs.
Who are the key members and board of directors at Vaxicare Enterprises?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bharti  | Director | 21-Sep-2020 | Current |
| Manoj Nailwal | Director | 16-Apr-2019 | Current |
Financial Performance of Vaxicare Enterprises.
Vaxicare Enterprises Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14.14% increase. The company also saw a substantial improvement in profitability, with a 13.95% increase in profit. The company's net worth Soared by an impressive increase of 58.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaxicare Enterprises?
In 2020, Vaxicare Enterprises had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹22.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 2.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Feb 2021 | Others | ₹2.20 Cr | Open |
How Many Employees Work at Vaxicare Enterprises?
Unlock and access historical data on people associated with Vaxicare Enterprises, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaxicare Enterprises, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaxicare Enterprises's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
